Is AKABY or NOBL a better dividend investment in 2026?

AKABY currently yields 0.50% with a 5% 5-year dividend growth rate. NOBL yields 4.00% with 5% growth. The better choice depends on your goal: NOBL offers higher current income.

What is the dividend yield difference between AKABY and NOBL?

AKABY has a forward dividend yield of 0.50% ($0.45/share annually). NOBL yields 4.00% ($2.00/share annually). The yield gap is 3.50 percentage points.

Home › Compare › AKABY vs NOBL

AKABY vs NOBL: Dividend Comparison 2026

AKABY yields 0.50% · NOBL yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NOBL wins by $8.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

AKABY

● Live price

0.50%

Share price

$90.00

Annual div

$0.45

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$19.8K

Annual income

$0.05

Full AKABY calculator →

NOBL

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full NOBL calculator →

Portfolio growth — AKABY vs NOBL

📍 NOBL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AKABY	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AKABY + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AKABY pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AKABY

Annual income on $10K today (after 15% tax)

$42.27/yr

After 10yr DRIP, annual income (after tax)

$0.04/yr

NOBL

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, NOBL beats the other by $764.27/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AKABY + NOBL for your $10,000?

AKABY: 50%NOBL: 50%

100% NOBL50/50100% AKABY

Portfolio after 10yr

$23.9K

Annual income

$449.62/yr

Blended yield

1.88%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AKABY buys

NOBL buys

No recent congressional trades found for AKABY or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAKABYNOBL

Forward yield	0.50%	4.00% ✓
Annual dividend / share	$0.45	$2.00 ✓
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	-50%	5% ✓
Portfolio after 10y	$19.8K	$28.0K ✓
Annual income after 10y	$0.05	$899.19 ✓
Total dividends collected	$50.00 ✓	$6.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: AKABY vs NOBL ($10,000, DRIP)

Year	AKABY Portfolio	AKABY Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$10,725	$24.87	$11,120	$420.00	$395.00 → NOBL
2	$11,488	$12.46	$12,357	$458.31	$869.00 → NOBL
3	$12,298	$6.24	$13,721	$499.76	$1.4K → NOBL
4	$13,162	$3.12	$15,227	$544.58	$2.1K → NOBL
5	$14,085	$1.56	$16,885	$593.02	$2.8K → NOBL
6	$15,072	$0.78	$18,713	$645.34	$3.6K → NOBL
7	$16,128	$0.39	$20,724	$701.81	$4.6K → NOBL
8	$17,257	$0.20	$22,938	$762.73	$5.7K → NOBL
9	$18,465	$0.10	$25,372	$828.41	$6.9K → NOBL
10	$19,757	$0.05	$28,047	$899.19	$8.3K → NOBL

AKABY vs NOBL: Complete Analysis 2026

AKABY — Stock

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.

Full AKABY Calculator →

NOBL — ETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →

📬

Get this AKABY vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AKABY vs SCHD AKABY vs JEPI AKABY vs O AKABY vs KO AKABY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.